'Ovarian cancer therapeutics' presentation slideshows

R&I: Ovarian Cancer Therapeutics in Major Developed Markets

The current developmental pipeline addresses these gaps in the market, with five of the 10 late stage pipeline molecules indicated as maintenance therapies, and three of the 10 indicated in platinum-resistant disease. Detailed report at: http://www.reportsandintelligence.com/ovarian-cancer-therapeutics-in-major-developed-to-2020-late-stage-pipeline-focuses-on-improved-progression-free-surival-and-targeted-therapies-market

287 views • 10 slides